Our goal is to provide state-of-the-art mass spectrometry services and expertise while expanding mass spectrometry application across various clinical disciplines and pharmacology. SC3 is poised to become the regional mass spectrometry reference centre for clinical diagnostics.
SC3 will be offering the following tests as a licensed clinical service:
Both tests are developed using liquid chromatography tandem mass spectrometer (LC-MS/MS) and have been validated rigorously based on CLSI (Clinical & Laboratory Standards Institute) guidelines.
Clinically, the measurement of plasma aldosterone and renin activity is important in the investigation of
primary aldosteronism (e.g. adrenal adenoma/carcinoma and adrenal cortical hyperplasia).
Changi General Hospital: Hypertension Precision Care & Primary Aldosteronism (Japanese Subtitles)
SC3 offers targeted mass spectrometry services for relative/absolute quantification of target peptides, hormones, drugs, metabolites using multiple reaction monitoring (MRM). Applicable sample types include blood, plasma, serum, urine and other biological fluids.
Call For Collaboration
With the enabling technology of mass spectrometry and biosafety level 2 (BSL2) facility, SC3 invites companies and/or organisations to co-develop novel clinical tests and applications with CGH. Please
contact us for more information.
Sending Clinical Samples to SC3
Please get in touch with us for more information.
Overseas customers should ensure compliance to applicable laws and regulations in their home country when procuring clinical laboratory services from SC3.
Subscribe to our mailing list to get the updates to your email inbox...